Bioinvent International AB

Where the EU money came from

Funding by EU programme. Amounts are Bioinvent International AB's own share of each project, not the project's full budget.

Projects

3 EU-funded projects, newest first. Bioinvent International AB led 1 of them as coordinator. Each links to the official record.

• BI-MARKCoordinator

  Clinical validation of the CD32b biomarker on the European market

  Horizon 2020 · 2015–2015 · Project on CORDIS ↗

  €50ktheir share
• IACTPartner

  Immunostimulatory Agonist antibodies for Cancer Therapy

  FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  €448ktheir share
• EUCAADPartner

  European Consortium for Anticancer Antibody Development

  FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

  €1.1Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Karolinska InstitutetSweden · 1 shared project
• University of SouthamptonUnited Kingdom · 1 shared project
• Universita Degli Studi di TorinoItaly · 1 shared project
• Universite D'Aix MarseilleFrance · 1 shared project
• Deutsches Krebsforschungszentrum HeidelbergGermany · 1 shared project
• Universitatsklinikum HeidelbergGermany · 1 shared project
• Universidad de NavarraSpain · 1 shared project
• Martin-Luther-Universitat Halle-WittenbergGermany · 1 shared project
• Fondazione Irccs Istituto Nazionale Dei TumoriItaly · 1 shared project
• Fundacion Para la Investigacion Medica Aplicada FimaSpain · 1 shared project
• Universita Degli Studi Gabriele D'Annunzio di Chieti-PescaraItaly · 1 shared project
• Philochem AGSwitzerland · 1 shared project
• Biontech Rna Pharmaceuticals GmbHGermany · 1 shared project
• Protagen AGGermany · 1 shared project
• Leadartis S.l.Spain · 1 shared project
• Glycotope GmbHGermany · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• business models
• drug discovery
• immunology
• oncology